Page last updated: 2024-11-05

zolpidem and Complex Regional Pain Syndromes

zolpidem has been researched along with Complex Regional Pain Syndromes in 1 studies

Zolpidem: An imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA.
zolpidem : An imidazo[1,2-a]pyridine compound having a 4-tolyl group at the 2-position, an N,N-dimethylcarbamoylmethyl group at the 3-position and a methyl substituent at the 6-position.

Complex Regional Pain Syndromes: Conditions characterized by pain involving an extremity or other body region, HYPERESTHESIA, and localized autonomic dysfunction following injury to soft tissue or nerve. The pain is usually associated with ERYTHEMA; SKIN TEMPERATURE changes, abnormal sudomotor activity (i.e., changes in sweating due to altered sympathetic innervation) or edema. The degree of pain and other manifestations is out of proportion to that expected from the inciting event. Two subtypes of this condition have been described: type I; (REFLEX SYMPATHETIC DYSTROPHY) and type II; (CAUSALGIA). (From Pain 1995 Oct;63(1):127-33)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Horisawa, S1
Ando, T1
Kawamata, T1
Taira, T1

Other Studies

1 other study available for zolpidem and Complex Regional Pain Syndromes

ArticleYear
Complex regional pain syndrome after mRNA-based COVID-19 vaccination.
    Clinical neurology and neurosurgery, 2023, Volume: 224

    Topics: Adolescent; Baclofen; Complex Regional Pain Syndromes; COVID-19; COVID-19 Vaccines; Female; Humans;

2023